LATEST
Maximus Federal Services agreed to acquire Agile DefensenewMount Logan Management agreed to acquire Alternative Fund AdvisorsnewDime Commercial Bancshares / ES BancsharesnewSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsMorgan Stanley Capital Partners acquired The Rapid GroupCBRE Group agreed to acquire Onnec GroupBevPoint Capital agreed to acquire ESGMarwynn Holdings acquired Zhituo SoftwareAspire-Lakewood Holding acquired Dura Driver Control SystemsTransom Signal MergerSub / SoundThinkingSilgan / Trivium: minority stake
Open App
ClosedPublished 9 Aug 2023

Lilly /
DICE

Lilly completes acquisition of DICE Therapeutics

Buy side: Lilly
Buy sideLilly
Target: DICE
TargetDICE
Source · 9 Aug 2023
See the source
Buy side: Lilly
Buy sideLilly
Target: DICE
TargetDICE
01 / BuyerLilly
02 / TargetDICE
01

What happened

Lilly completed its acquisition of DICE Therapeutics on Aug. 9, 2023, through a merger in which DICE survived as a wholly owned subsidiary of Lilly. The offer price was $48.00 per share.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Lilly completes acquisition of DICE Therapeutics

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.